You are here
Hep C Knowledge Bank
Konerman MA. et al. (2014) Systematic review: identifying patients with chronic hepatitis C in need of early treatment and intensive monitoring–predictors and predictive models of disease progression. Alimentary Pharmacology & Therapeutics, 40(8):863-879.
Kohli A. et al. (2014) Treatment of hepatitis C: a systematic review. JAMA, 312(6):631-640.
Esmat G. et al. (2014) Optimizing treatment for HCV genotype 4: PEG-IFN alfa 2a vs. PEG-IFN alfa 2b; the debate continues. Liver International, 34(Suppl 1):24-28.
Cheng D. et al. (2014) Peginterferon plus Chinese herbal therapy is associated with a higher virological response than only peginterferon therapy in chronic hepatitis C. European Journal of Clinical Microbiology & Infectious Diseases, 33(3):433-438.
Wedemeyer H. et al. (2014) Strategies to manage hepatitis C virus (HCV) infection disease burden. Journal of Viral Hepatitis, 21(1):60-89.
MacArthur. et. al. (2014). Interventions to prevent HIV and hepatitis C in people who inject drugs: a review of reviews to assess evidence of effectiveness. International Journal of Drug Policy, 25(1), 34-52.
Zheng, M. et. al. (2013). Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians. Gene, 518(2), 479-482.
Villar, L. M. et. al. (2013). Association between vitamin D and hepatitis C virus infection: a meta-analysis. World Journal of Gastroenterology: WJG, 19(35), 5917.
Tsiara CG. et al. (2013) Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis. Journal of Viral Hepatitis, 20(10):715-724.
Pages
